References
- Chiyo M, Shimozato O, Yu L. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int J Cancer 2005;115:437–42
- Nagai H, Oniki S, Fujiwara S. Antitumor activities of interleukin-27 on melanoma. Endocr Metab Immune Disord Drug Targets 2010;10:41–6
- Gao X, Huang M, Liu L. Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations. PLoS One 2013;8:e55169
- Gao X, Duan H, Zhu Z. Association between PTEN IVS4 polymorphism and cancer risk: a meta-analysis. Cancer Biomark 2013;13:465–70
- Zhang Z, Zhou B, Wu Y. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population. Immunogenetics 2014;66:85–92
- Peng Q, Qin X, He Y. Association of IL27 gene polymorphisms and HBV-related hepatocellular carcinoma risk in a Chinese population. Infect Genet Evol 2013;16:1–4
- Huang ZQ, Wang JL, Pan GG. Association of single nucleotide polymorphisms in IL-12 and IL-27 genes with colorectal cancer risk. Clin Biochem 2012;45:54–9
- Tao YP, Wang WL, Li SY. Associations between polymorphisms in IL-12A, IL-12B, IL-12Rβ1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer. J Cancer Res Clin Oncol 2012;138:1891–900
- Wei YS, Lan Y, Luo B. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Mol Carcinog 2009;48:751–7
- Zhao B, Meng LQ, Huang HN. A novel functional polymorphism, 16974 A/C, in the interleukin-12-3′ untranslated region is associated with risk of glioma. DNA Cell Biol 2009;28:335–41